Skip to main content
drug protocol number
Version 1.3.1
drug sponsor
Abbvie Biopharmaceuticals GmbH / KSU Liver Disease Research Center
drug study
ombitasvir \ paritaprevir \ ritonavir
drug trial site
NGHA-J
drug status
Ongoing
drug phase